ACHIEVE-3 was the head-to-head trial against oral semaglutide in T2D (1,698 patients, 52 weeks), showing orforglipron superiority
[cited 2024 Mar 5]
Reactive oxygen species in HIV infection
Research suggests separating retinoid and copper peptide applications by at least 30 minutes, or better yet, using them on alternate nights
Perhaps, but not to such a degree, says Charlie Seltzer, M.D., a Philadelphia-based obesity specialist
Warning signs include: Dizziness upon standing Decreased urination or dark urine Dry mouth and increased thirst Muscle weakness or cramping Other Concerning Symptoms Immediate medical attention is warranted if fatigue occurs with: Severe abdominal pain (may indicate pancreatitis) Right upper quadrant pain, fever, or yellowing of skin/eyes (signs of gallbladder disease) Persistent vomiting preventing fluid intake Visual changes or severe headache (especially in patients with diabetes and retinopathy) Chest pain or shortness of breath Signs of allergic reaction (rash, swelling, difficulty breathing) The American Diabetes Association Standards of Care recommend regular monitoring of patients on GLP-1 receptor agonists, including assessment of tolerability, glycemic control, weight changes, and overall well-being
